Drugs

Order of the Supreme Court regarding ART drugs for people living with HIV/AIDS, 24/02/2025

Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …

Nothing Free In This Trade Pact

The EU-India agreement might not stop generic drug seizures at European portsJust a few months ago, Indian officials were up in arms against the European Union (EU) after several generic drug consignments en route to Latin America and Africa had been seized by EU customs. Subsequently, commerce ministry officials vowed …

Vested interests behind discussion on patents

Civil Society Groups Urge End To India Project, Allege Nexus With MNC Pharma Companies Several civil society groups have come together to question the commerce and industry ministry

For both IPR & access to medicines

TK ARUN STEFAN Oschmann is president, Emerging Markets, at Merck, the world's second largest pharmaceuticals company after its 2009 merger with Schering-Plough, with a combined global revenue in 2009 of $27.4 billion. Now, if that doesn't look very large these days, with the individual worth of each of the top …

AIDS drugs centre for all districts

Gwalior: With Madhya Pradesh reporting over 400 new HIV-AIDS cases in 2009, medical centres are to be set up in every district so that patients, especially rural ones, can get treatment without having to travel long distances. The directive to create more Antiretroviral Therapy (ART) link centres was issued by …

Scientists claim new TB drug could be cure

Australian scientists on Wednesday claimed to have discovered a protein and were developing a drug that could cure tuberculosis which claims about 1,000 lives daily in India alone. Researchers at Sydney

Bayer files patent case against Cipla

GERMAN drugmaker Bayer has filed a patent infringement case against Cipla, the largest domestic drugseller, to stop the Mumbaibased company from selling its generic version of Bayer

Delhi HC rejects BMS plea to ban Ranbaxy generic

THE Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India

FDA warning on use of Rotarix vaccine

US regulatory body Food and Drug Administration (FDA) has recommended that the use of Rotarix, a vaccine used to prevent rotavirus disease that causes severe diarrhoea and dehydration in children, be suspended. The body says that though there is at present no evidence that Rotarix poses a safety risk, the …

WHO: Half of drug-resistant TB patients in India, China

Almost half of the estimated 4,40,000 cases of multi-drug resistant tuberculosis in 2008 were reported from India and China, a World Health Organisation (WHO) report has revealed.

Glenmark asked to stop sale of unapproved drugs

New Delhi: The US Food and Drug Administration (FDA) has ordered domestic company, Glenmark Generics to stop marketing

First batch of imported H1N1 vaccine sent to states

Confirmed to be safe for human use by the Drug Controller General of India, the first consignment of imported H1N1 vaccine manufactured by French firm Sanofi Pasteur was dispatched from Delhi to various states on Tuesday. Of the 1.5 million doses imported by the Health Ministry, about 5 lakh doses …

Cash crisis looms for vaccine drive

Up to 4.2 million people, mostly young children, will die needlessly over the next 6 years unless donors fill a looming multibillion-dollar shortfall in the budget of the GAVI Alliance.

Central team to probe MP vaccine deaths

Bhopal: Union health ministry has rushed a team of vaccination experts to investigate the death of four infants in Damoh town in north Madhya Pradesh. Twenty infants below the age of two years were administered tetanus and antimeasles vaccine in two anganwadi centres on Friday. Four of these children, aged …

Soon, free TB drugs at 150

In an effort to make tuberculosis (TB) treatment easily available, about 150 retail chemist outlets in the north east region of the city have decided to provide DOTS (Directly Observed Treatment, Short course) medicines for free. Chemists in Mulund, Chembur, Navi Mumbai and Kalyan will start DOTS counseling and treatment …

Central team: Measles vaccine contamination may have caused deaths

The four children who were administered an anti-measles shot died due to mishandling of the vaccine by the health worker, says a four-member team sent by the Union Health Ministry to Madhya Pradesh on Monday to inquire into the deaths. While the team

WHO, Unicef ban use of Shantha vaccine

THE World Health Organisation (WHO) and Unicef have suspended the use and purchase of Shan5 vaccine from Sanofi Aventis-owned Shantha Biotechnics, pending a quality investigation that threatens a three-year contract worth $350 million. The investigation follows complaints from Colombia, Nepal and Comoros

Ranbaxy settles patent dispute with Takeda

RANBAXY Laboratories on Monday announced it has settled a patent dispute with Takeda Pharmaceutical allowing the Gurgaon-based drugmaker to launch its generic tablets of Takeda

A jab back

On February 15, medical journal Lancet issued a historic retraction. It took back a paper that drew a link between vaccines and autism and helped fuel a backlash against immunization of children. In 1998 a Lancet paper reported dozen kids developed various behavioral problems. Eight of them had been vaccinated …

No patent linkage

The Delhi High Court refused a patent linkage to multinational pharma company Bayer’s for its cancer drug sorefenib tosylate, sold under the name Nexavar. This means there is no restriction on the drug controller to approve generic versions of patent drugs. Bayer holds the patent for sorenfenib, used to treat …

AstraZeneca teams up with Torrent for 18 generic drugs

Ahmedabad: Leading UK drugmaker AstraZeneca Plc will brand and market 18 medicines manufactured by the Rs 1,600-crore Ahmedabad-based pharma company Torrent Pharmaceuticals in 9 emerging economies. AstraZeneca follows UK peer GlaxoSmithKline Plc and Sanofi-Aventis SA of France in its foray into the growing market for lowerpriced copied medicines as drugmakers …

  1. 1
  2. ...
  3. 85
  4. 86
  5. 87
  6. 88
  7. 89
  8. ...
  9. 151

IEP content by date loading...
IEP child categories loading...